Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · IEX Real-Time Price · USD
11.20
+0.15 (1.36%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Astria Therapeutics Employees
Astria Therapeutics had 59 employees as of December 31, 2023. The number of employees increased by 17 or 40.48% compared to the previous year.
Employees
59
Change (1Y)
17
Growth (1Y)
40.48%
Revenue / Employee
n/a
Profits / Employee
-$1,383,576
Market Cap
615.03M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ZimVie | 2,600 |
Ginkgo Bioworks Holdings | 1,218 |
REGENXBIO | 344 |
ProKidney | 163 |
KalVista Pharmaceuticals | 150 |
Celcuity | 55 |
ArriVent BioPharma | 40 |
Corbus Pharmaceuticals Holdings | 19 |
ATXS News
- 19 days ago - Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference - Business Wire
- 2 months ago - Astria Therapeutics to Present at Upcoming Eastern Allergy Conference - Business Wire
- 2 months ago - Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress - Business Wire
- 2 months ago - Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update - Business Wire
- 2 months ago - Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual Meeting - Business Wire
- 3 months ago - Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors - Business Wire
- 4 months ago - Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE - Business Wire